These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2538330

  • 1. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
    Luis J, Martin JM, el Battari A, Reynier M, Marvaldi J, Pichon J.
    Eur J Biochem; 1989 Mar 15; 180(2):429-33. PubMed ID: 2538330
    [Abstract] [Full Text] [Related]

  • 2. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
    Martin JM, Luis J, Marvaldi J, Pichon J, Pic P.
    Eur J Biochem; 1989 Mar 15; 180(2):435-9. PubMed ID: 2538331
    [Abstract] [Full Text] [Related]

  • 3. Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. Alteration of receptor function by wheat germ agglutinin.
    Chochola J, Fabre C, Bellan C, Luis J, Bourgerie S, Abadie B, Champion S, Marvaldi J, el Battari A.
    J Biol Chem; 1993 Feb 05; 268(4):2312-8. PubMed ID: 8381403
    [Abstract] [Full Text] [Related]

  • 4. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
    el Battari A, Martin JM, Luis J, Pouzol O, Secchi J, Marvaldi J, Pichon J.
    J Biol Chem; 1988 Nov 25; 263(33):17685-9. PubMed ID: 2846575
    [Abstract] [Full Text] [Related]

  • 5. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V, Farjaudon N, Bawab W, Chastre E, Rosselin G, Guilloteau P, Gespach C.
    Am J Physiol; 1991 Feb 25; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [Abstract] [Full Text] [Related]

  • 6. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A, Rousset M, Laburthe M.
    Biochem J; 1985 Oct 01; 231(1):139-43. PubMed ID: 2998337
    [Abstract] [Full Text] [Related]

  • 7. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
    Dickinson KE, Schachter M, Miles CM, Coy DH, Sever PS.
    Peptides; 1986 Oct 01; 7(5):791-800. PubMed ID: 3025822
    [Abstract] [Full Text] [Related]

  • 8. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
    Paul S, Said SI.
    J Biol Chem; 1987 Jan 05; 262(1):158-62. PubMed ID: 3025200
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M.
    Am J Physiol; 1993 Feb 05; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [Abstract] [Full Text] [Related]

  • 10. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
    Martin JM, Darbon H, Luis J, el Battari A, Marvaldi J, Pichon J.
    Biochem J; 1988 Mar 15; 250(3):679-85. PubMed ID: 2839143
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 12. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
    Mao YK, Barnett W, Coy DH, Tougas G, Daniel EE.
    J Pharmacol Exp Ther; 1991 Sep 15; 258(3):986-91. PubMed ID: 1653848
    [Abstract] [Full Text] [Related]

  • 13. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
    Couvineau A, Gammeltoft S, Laburthe M.
    J Neurochem; 1986 Nov 15; 47(5):1469-75. PubMed ID: 3020175
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the expression of the VIP receptor by serum factors on the human melanoma cell line IGR39.
    Bellan C, Fabre C, Secchi J, Marvaldi J, Pichon J, Luis J.
    Exp Cell Res; 1992 May 15; 200(1):34-40. PubMed ID: 1314189
    [Abstract] [Full Text] [Related]

  • 15. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE, Wood CL, O'Dorisio MS, Zhou ZC, Gardner JD, Jensen RT.
    Am J Physiol; 1987 Mar 15; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M, Carlquist M, Maletti M, Marie JC.
    FEBS Lett; 1993 Feb 22; 318(1):35-40. PubMed ID: 8382169
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
    Van Valen F, Jürgens H, Winkelmann W, Keck E.
    Cell Signal; 1989 Feb 22; 1(5):435-46. PubMed ID: 2561912
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
    Nguyen TT, Krco CJ, Gores A, Go VL.
    Immunol Invest; 1987 Nov 22; 16(7):555-77. PubMed ID: 2832322
    [Abstract] [Full Text] [Related]

  • 19. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
    Provow S, Veliçelebi G.
    Endocrinology; 1987 Jun 22; 120(6):2442-52. PubMed ID: 3032591
    [Abstract] [Full Text] [Related]

  • 20. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents.
    Fouchier F, Forget P, Pic P, Marvaldi J, Pichon J.
    Eur J Cell Biol; 1992 Dec 22; 59(2):382-8. PubMed ID: 1337321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.